Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Surg Laparosc Endosc Percutan Tech ; 25(4): 286-96, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26241295

RESUMEN

PURPOSE: It is to disclose whether the laparoscopic technique is feasible or not in the treatment of low rectal cancer. MATERIALS AND METHODS: We systematically searched PubMed, Embase, Ovid, Web of Science, Science Direct, SpringerLink, EBSCO, and the Cochrane Library databases for the eligible studies. Review Manager 5.2 was used to test the heterogeneity and to evaluate the overall test performance. RESULTS: Twelve studies met the final inclusion criteria (total n=2973). The pooled analyses showed, despite longer operation times, that there were significantly less blood loss, fewer transfusions, shorter times to bowel function recovery, resumed diet and hospital durations, and lower overall complication and wound infection rates. The compared results of the lymph node harvest number, distal resection margin, circumferential resection margin involvement, local and distant recurrences, disease-free survival, and overall survival were similar between both the groups. CONCLUSION: Laparoscopic surgery is safe and feasible for the treatment of low rectal cancer.


Asunto(s)
Colectomía/métodos , Laparoscopía/métodos , Laparotomía/métodos , Neoplasias del Recto/cirugía , Estudios de Seguimiento , Humanos , Tempo Operativo , Factores de Tiempo , Resultado del Tratamiento
2.
J Gastrointest Surg ; 19(8): 1497-512, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26040854

RESUMEN

BACKGROUND: The safety of laparoscopic surgery for mid-low rectal cancer treatment has remained controversial, especially regarding the long-term outcomes. The aim of this study was to demonstrate whether the laparoscopic technique is feasible. METHODS: We searched all of studies that compared the short- or long-term outcomes regarding laparoscopic and open rectal cancer surgeries (the tumour distance from anal verge within 10 cm). The data sources included PubMed, EMBASE, OVID, Web of Science and the Cochrane Library databases. The combined outcome of the dichotomous variables was expressed as an estimation of the odds ratios and continuous variables were presented in the form of weighted mean differences with 95% credible intervals. Subgroup, publication bias and sensitivity analyses were performed. RESULTS: Thirteen studies met the final inclusion criteria (total n = 3,678). The pooled analyses showed, despite longer operation times, that there were significantly less blood loss, fewer transfusions, shorter times to bowel function recovery, resumed diet and hospital durations, and lower overall complication and wound infection rates. The compared results of the lymph node harvest number, distal resection margin, circumferential resection margin involvement, local and distant recurrences, disease-free survival and overall survival were similar between both groups. CONCLUSIONS: This study suggests that the safety and feasibility of laparoscopic surgery appear to be equivalent to open surgery for treatment of mid- low rectal cancer, with the more favourable short-term benefits, fewer complications, comparable pathological outcomes and long-term outcomes.


Asunto(s)
Carcinoma/cirugía , Ganglios Linfáticos/patología , Neoplasias del Recto/cirugía , Supervivencia sin Enfermedad , Humanos , Laparoscopía/métodos , Oportunidad Relativa , Tempo Operativo , Resultado del Tratamiento
3.
Asian Pac J Cancer Prev ; 14(9): 5089-93, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24175781

RESUMEN

OBJECTIVE: This study aimed to investigate the effects of BCRP expression on tumor recurrence, metastasis and treatment tolerability. METHODS: A VX2 rabbit liver tumor model was established. Division was randomly into 4 groups: namely saline control group; A group, given hydration lipiodol; B group, Ad-p53; and C group, Ad-p53+hydration lipiodol. After the intervention, samples were collected to detect the BCRP, MMP-2, VEGF and PCNA. RESULTS: The expression of BCRP, MMP-2, PCNA and VEGF in tumors in Group A had no significant difference when compared with the control group, while in B and C group, the values were significantly lower (P < 0.05). BCRP positive expression in metastatic lesions significantly increased (P < 0.05), and was correlated with MMP-2 (X2=6.172, P = 0.0131). CONCLUSIONS: BCRP may play an important role in mediating liver cancer multidrug resistance to chemotherapy, and may be correlated with tumor recurrence and metastasis, which leads to weakened treatment effect. Ad-P53 can down-regulate the expression of related genes, playing a role in multidrug resistance reversal and increased sensitivity in liver cancer treatment.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Antineoplásicos/farmacología , Aceite Etiodizado/farmacología , Neoplasias Hepáticas Experimentales/metabolismo , Metaloproteinasa 2 de la Matriz/metabolismo , Recurrencia Local de Neoplasia/metabolismo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Animales , Antineoplásicos/uso terapéutico , Resistencia a Múltiples Medicamentos/genética , Aceite Etiodizado/uso terapéutico , Neoplasias Hepáticas Experimentales/tratamiento farmacológico , Metástasis de la Neoplasia , Conejos
4.
J Ethnopharmacol ; 141(2): 659-67, 2012 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-21903157

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Salvia miltiorrhiza and Panax notoginseng are popularly used traditional Chinese medicine for cardiovascular disorders and they are often used in the form of combination. However, mechanisms of their cardioprotective effects were still not clear. In the present study, the protective effects of salvianolic acids (SA), notoginsengnosides (NG) and combination of SA and NG (CSN) against rat cardiac ischemia-reperfusion injury were checked and the protein expression profiles of heart tissues were examined to search their possible protein targets. MATERIALS AND METHODS: The cardioprotective effects of SA, NG and CSN were checked in a rat model of ischemia-reperfusion (IR) by temporarily occluding coronary artery for 20 min followed by reperfusion. Rats were grouped into sham-operation group, IR group, IR+SA group, IR+NG group and IR+CSN group. The plasma creatine kinase (CK) activities were measured using commercial kit and the percentages of infarcted area in total ventricle tissue were calculated after nitroblue-tetrazolium (N-BT) staining of heart tissue slices. Two-dimensional protein electrophoresis (2-DE) was used to check the protein expression profiles of heart tissues. Then, proteins differentially expressed between IR group and sham-operation group were identified using matrix assisted laser desorption ionization-time of flight-mass spectrometry/mass spectrometry (MALDI-TOF MS/MS). The regulative effects of SA, NG and CSN on these IR-related proteins were analyzed. RESULTS: Treatments including SA, NG and CSN all showed cardioprotective effects against ischemia-reperfusion injury and CSN exhibited to be the best. Eighteen proteins involved in IR injury were found. These proteins are involved in pathways including energy metabolism, lipid metabolism, muscle contraction, heat shock stress, cell survival and proliferation. The regulation of these proteins by SA, NG or CSN suggested possible protein targets in their cardioprotective effects. CONCLUSIONS: SA and NG showed both similarity and difference in their protein targets involved in cardioprotective effects. The capability of CSN to regulate both protein targets of SA and NG might be the basis of CSN to show cardioprotective effects better than that of SA or NG.


Asunto(s)
Alquenos/farmacología , Medicamentos Herbarios Chinos/farmacología , Infarto del Miocardio/prevención & control , Daño por Reperfusión Miocárdica/prevención & control , Miocardio/metabolismo , Panax notoginseng , Polifenoles/farmacología , Proteómica , Salvia miltiorrhiza , Saponinas/farmacología , Alquenos/aislamiento & purificación , Animales , Creatina Quinasa/sangre , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/aislamiento & purificación , Electroforesis en Gel Bidimensional , Masculino , Medicina Tradicional China , Infarto del Miocardio/metabolismo , Infarto del Miocardio/patología , Daño por Reperfusión Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/patología , Miocardio/patología , Panax notoginseng/química , Plantas Medicinales , Polifenoles/aislamiento & purificación , Proteómica/métodos , Ratas , Ratas Wistar , Salvia miltiorrhiza/química , Saponinas/aislamiento & purificación , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Factores de Tiempo
5.
J Nat Prod ; 72(4): 799-801, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19278239

RESUMEN

A pair of new flavanol racemates (1a and 1b) and a new flavanol racemic mixture (2) were isolated from crude propolis from Henan Province, People's Republic of China. Also obtained were nine known compounds, including two flavones, four flavonols, two flavanols, and isoferulic acid. Spectroscopic analysis was employed to assign the structures of these new compounds and the absolute configurations of 1a and 1b. Cytotoxicity of the isolated compounds against the HeLa human cervical carcinoma cancer cell line was evaluated, with only compounds 1a, 1b, 2, and rhamnetin (3) being active.


Asunto(s)
Antineoplásicos Fitogénicos/aislamiento & purificación , Antineoplásicos Fitogénicos/farmacología , Medicamentos Herbarios Chinos/aislamiento & purificación , Medicamentos Herbarios Chinos/farmacología , Flavonoles/aislamiento & purificación , Flavonoles/farmacología , Própolis/química , Quercetina/análogos & derivados , Antineoplásicos Fitogénicos/química , Ensayos de Selección de Medicamentos Antitumorales , Medicamentos Herbarios Chinos/química , Femenino , Flavonoles/química , Humanos , Estructura Molecular , Quercetina/química , Quercetina/aislamiento & purificación , Quercetina/farmacología , Estereoisomerismo
6.
Cancer Sci ; 99(7): 1461-70, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18422750

RESUMEN

Triterpenes are the main components with cytotoxicity in Ganoderma lucidum, which is used popularly as a complementary treatment for cancer therapy in traditional Chinese medicine. To investigate the possible interaction between chemotherapeutic agents and triterpenes extracted from G. lucidum, the cytotoxicity of doxorubicin (DOX) combined with Ganoderma triterpenes (GTS) or lucidenic acid N (LCN), a purified compound, was examined in HeLa cells. The combinations targeting DOX with GTS or LCN resulted in a synergistic interaction in HeLa cells. Moreover, to identify the molecular targets of GTS, two-dimensional gel electrophoresis-based comparative proteomics was carried out and proteins with altered expression levels after GTS treatment in HeLa cells were identified by matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry. The results of our proteomic study indicated that the GTS treatment caused regulated expression of 14 proteins, which play important roles in cell proliferation, the cell cycle, apoptosis, and oxidative stress. Flow cytometric analysis confirmed that GTS could induce weak G(0)-G(1) phase arrest and combined use of GTS with DOX could induce apoptosis in cells. Furthermore, GTS enhanced the reactive oxygen species (ROS)-producing effect of DOX, and a ROS scavenger could affect the synergism between GTS and DOX. In cells with high Ku80 protein expression, the synergism between GTS and DOX was also partly affected. Importantly, in cells with high Ku80 expression that were treated with a ROS scavenger, the synergism between GTS and DOX totally disappeared. These results suggest that the synergism between GTS and DOX might be based on GTS-induced sensitization of cells to chemotherapeutics through enhanced oxidative stress, DNA damage, and apoptosis.


Asunto(s)
Doxorrubicina/farmacología , Ganoderma/química , Proteínas de Neoplasias/análisis , Proteómica , Triterpenos/farmacología , Antígenos Nucleares/análisis , Western Blotting , Ciclo Celular/efectos de los fármacos , Proteínas de Unión al ADN/análisis , Sinergismo Farmacológico , Células HeLa , Humanos , Autoantígeno Ku , Proteína Fosfatasa 2/fisiología , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA